---
figid: PMC5899637__nihms941139f1
figlink: /pmc/articles/PMC5899637/figure/F1/
number: F1
caption: (Left panel) The blood-tumor-barrier associated with BCBMs has increased
  permeability mediated by desmin-positive pericytes and altered tight junctions.
  Although this allows trastuzumab to penetrate the brain parenchyma, inhibition of
  HER2 alone (Right panel, dashed arrow) is counteracted by brain-specific resistance
  mechanisms (see text for details). (Right panel) Brain-specific drug resistance
  mechanisms in BCBMs include loss of PTEN expression and activation of the PI3K-AKT-mTOR
  pathway as well as activation of parallel signaling pathways via neuregulin-HER3
  axis. Drug inhibition of these targets (colored bar-headed line) shows promising
  efficacy in pre-clinical models.
pmcid: PMC5899637
papertitle: 'Drug resistance in HER2-positive breast cancer brain metastases: blame
  the barrier or the brain?.'
reftext: Sheheryar Kabraji, et al. Clin Cancer Res. ;24(8):1795-1804.
pmc_ranked_result_index: '3290'
pathway_score: 0.9339647
filename: nihms941139f1.jpg
figtitle: 'Drug resistance in HER2-positive breast cancer brain metastases: blame
  the barrier or the brain?'
year: ''
organisms:
- Mus musculus
- Mouse mammary tumor virus
- Homo sapiens
ndex: 4e67cf6a-de99-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5899637__nihms941139f1.html
  '@type': Dataset
  description: (Left panel) The blood-tumor-barrier associated with BCBMs has increased
    permeability mediated by desmin-positive pericytes and altered tight junctions.
    Although this allows trastuzumab to penetrate the brain parenchyma, inhibition
    of HER2 alone (Right panel, dashed arrow) is counteracted by brain-specific resistance
    mechanisms (see text for details). (Right panel) Brain-specific drug resistance
    mechanisms in BCBMs include loss of PTEN expression and activation of the PI3K-AKT-mTOR
    pathway as well as activation of parallel signaling pathways via neuregulin-HER3
    axis. Drug inhibition of these targets (colored bar-headed line) shows promising
    efficacy in pre-clinical models.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TSC1
  - AKT3
  - CDK12
  - CDK14
  - AKT1
  - CDK18
  - CDK7
  - PTEN
  - CDK5
  - CDK6
  - CDK19
  - CDK20
  - PIK3R3
  - EIF4EBP1
  - PDK1
  - PIK3R6
  - PIK3R5
  - PIK3R4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - CDK9
  - CDKL1
  - CDKL2
  - CDKL4
  - CDKL3
  - CDK16
  - AKT2
  - CDK2
  - CDK3
  - CDK4
  - CDKL5
  - CDK11A
  - CDK8
  - CDK13
  - ERBB3
  - CDK17
  - CDK11B
  - ERBB2
  - CDK15
  - CDK10
  - CDK1
  - Phosphatidylinositol
  - bisphosphate
  - O
  - Phosphatidylinositol (3,4,5) trisphosphate
  - Everolimus
genes:
- word: TSC1
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK12
  entrez: '51755'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK14
  entrez: '5218'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK18
  entrez: '5129'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK7
  entrez: '1022'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK5
  entrez: '1020'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK19
  entrez: '23097'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK20
  entrez: '23552'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: 4E-BP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK9
  entrez: '1025'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL1
  entrez: '8814'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL2
  entrez: '8999'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL4
  entrez: '344387'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL3
  entrez: '51265'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK16
  entrez: '5127'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK3
  entrez: '1018'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL5
  entrez: '6792'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK11A
  entrez: '728642'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK8
  entrez: '1024'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK13
  entrez: '8621'
- word: HER3
  symbol: HER3
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK17
  entrez: '5128'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK11B
  entrez: '984'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK15
  entrez: '65061'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK10
  entrez: '8558'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK1
  entrez: '983'
chemicals:
- word: Phosphatidylinositol
  source: MESH
  identifier: D010716
- word: bisphosphate
  source: MESH
  identifier: C115960
- word: O
  source: MESH
  identifier: D013481
- word: Phosphatidylinositol (3,4,5) trisphosphate
  source: MESH
  identifier: C060974
- word: Everolimus
  source: MESH
  identifier: C107135
diseases: []
figid_alias: PMC5899637__F1
redirect_from: /figures/PMC5899637__F1
figtype: Figure
---
